Frontlight ResearchEarly access
Trial site
The Affiliated Cancer Hospital of Xinjiang Medical University
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Gastric and oesophageal cancer2 trials
- Chronic lymphocytic leukaemia1 trial
- Head and neck cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 28 trials
- Phase 35 trials
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting4 trials
- Completed3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Daiichi Sankyo2 trials
- Dizal Pharmaceuticals2 trials
- EMD Serono Research & Development Institute, Inc.2 trials
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
- Hansoh BioMedical R&D Company1 trial
- and 6 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
Recruiting
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Recruiting
Active, not recruiting
Recruiting
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
Active, not recruiting
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer2 recruiting
- Lung cancer2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026